Zymeworks Inc (ZYME) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zymeworks Inc   (NASDAQ: ZYME)


Zymeworks Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zymeworks Inc's ROI in the third quarter of 2026?
Zymeworks Inc achieved a return on average invested assets (ROI) of 8.45 % in its third quarter of 2026, this is above ZYME's average return on investment of -29.23%.
Zymeworks Inc invested over the 12 months ending in its third quarter of 2026 $512 million

ROI has improved compared to -41.33% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 432 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3310 to 3460.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 40.31 % -3.75 % -7.97 % -19.94 % -22.58 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 952 350 443 304 355
Return On Investment (TTM) 8.45 % -41.33 % -27.9 % -23.35 % -17.37 %
ZYME's Overall Ranking # 3460 # 3310 # 2310 # 3051 #
Seq. Investment Change TTM 41.14 % -1.37 % 5.91 % -4.83 % -3.18 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 43 -150 -103 -81 -63

ZYME Company Profile >> Back to ZYME Roi Comparisons >> See Annual ZYME Return On Investment



Return On Investment ZYME's Ranking
Within: No.
Industry # 171
Sector # 433
Overall # 3460

Return On Investment Statistics
High Average Low
42.67 %
-29.23 %
-88.95 %
(Mar 31 2023)   (Mar 31 2018)







Financial Statements
Zymeworks Inc's III. Quarter Investments $ 952 Millions ZYME's Balance sheet
Zymeworks Inc's III. Quarter Income $ 174 Millions Quarterly ZYME's Income Statement
ZYME's Income by Division See ZYME's Income by Division


ZYME Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 304 375 525 553 317
Y / Y Investment Growth -18.83 % -28.63 % -5.06 % 74.33 % -29.92 %
Net Income in Millions -81 -123 -119 124 -212
Y / Y Net Income Growth - - - - -
Annual Return On Investment -26.67 % -32.74 % -22.6 % 22.48 % -66.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZYME's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZYME's Competitors
Subscribers only: Roi for Zymeworks Inc's Suppliers
Subscribers only: Return On Investment for ZYME's Customers

Other Ratios
ZYME's Roa ZYME's Inventory Turnover Ratio ZYME's Growth Rates ZYME's Dividend Statistics
ZYME's Profitability Ratios ZYME's Asset Turnover Ratio ZYME's Dividend Growth
ZYME's Roe ZYME's Valuation Ratios ZYME's Financial Strength Ratios ZYME's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %

Date modified: 2026-11-10T10:04:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.